Surface Oncology, Inc. (SURF): Price and Financial Metrics


Surface Oncology, Inc. (SURF)

Today's Latest Price: $3.10 USD

0.19 (-5.78%)

Updated Feb 18 8:00pm

Add SURF to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

SURF Stock Summary

  • SURF's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 2.13 -- higher than just 10.6% of US-listed equities with positive expected earnings growth.
  • Surface Oncology Inc's stock had its IPO on April 19, 2018, making it an older stock than only 3.79% of US equities in our set.
  • The volatility of Surface Oncology Inc's share price is greater than that of 90.18% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Surface Oncology Inc are AGTC, CYTK, CLDX, APTX, and SGMO.
  • Visit SURF's SEC page to see the company's official filings. To visit the company's web site, go to www.surfaceoncology.com.
SURF Daily Price Range
SURF 52-Week Price Range

SURF Stock Price Chart More Charts


SURF Price/Volume Stats

Current price $3.10 52-week high $5.60
Prev. close $3.29 52-week low $1.15
Day low $3.07 Volume 79,400
Day high $3.25 Avg. volume 165,022
50-day MA $2.45 Dividend yield N/A
200-day MA $2.42 Market Cap 86.44M

Surface Oncology, Inc. (SURF) Company Bio


Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies. The company’s lead product candidate is the SRF231 that is in Phase I clinical trial targeting protein called cluster of differentiation (CD) 47. It is also developing SRF373 inhibiting CD73; SRF617 inhibiting CD39; and SRF388, an antibody targeting interleukin 27. The company has a collaboration agreement with Novartis Institutes for Biomedical Research, Inc. for the development of cancer therapies. Surface Oncology, Inc. was founded in 2014 and is based in Cambridge, Massachusetts.


SURF Latest News Stream


Event/TimeNews Detail
Loading, please wait...

SURF Latest Social Stream


Loading social stream, please wait...

View Full SURF Social Stream

SURF Price Returns

1-mo N/A
3-mo 46.92%
6-mo 58.16%
1-year -41.62%
3-year N/A
5-year N/A
YTD 64.89%
2019 -55.66%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6594 seconds.